- Report
- January 2026
- 189 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- March 2026
- 192 Pages
Global
From €5233EUR$5,850USD£4,530GBP
- Report
- January 2026
- 184 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- August 2025
- 198 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- February 2026
- 250 Pages
Global
From €4016EUR$4,490USD£3,477GBP
- Report
- July 2024
- 599 Pages
Global
From €4428EUR$4,950USD£3,833GBP
- Report
- April 2023
- 111 Pages
Global
From €4249EUR$4,750USD£3,679GBP
- Report
- July 2024
- 125 Pages
From €3086EUR$3,450USD£2,672GBP
- Report
- July 2024
- 140 Pages
North America
From €3086EUR$3,450USD£2,672GBP
- Report
- October 2023
- 150 Pages
Global
From €4339EUR$4,850USD£3,756GBP
- Report
- August 2024
- 91 Pages
Global
From €3500EUR$4,191USD£3,136GBP
The qPCR Reagent market is a subset of the biotechnology industry, focusing on the production and sale of reagents used in quantitative polymerase chain reaction (qPCR) tests. qPCR is a laboratory technique used to detect and quantify the presence of specific DNA or RNA sequences in a sample. qPCR reagents are used to amplify and detect these sequences, and are essential for the accurate and reliable performance of qPCR tests.
The qPCR Reagent market is highly competitive, with a range of companies offering products for different applications. Companies in the market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, Promega Corporation, Takara Bio, and QIAGEN. Show Less Read more
